NATALIE MENOSSI: Open Payments
NPI 1912195447 · GLEN CARBON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 49 payments from 13 companies in 2025. Trend: 2023 $963 · 2024 $362 · 2025 $883
Food & beverage: $845Education: $39
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $207 |
| Novo Nordisk Inc | 12 | $178 |
| ABBVIE INC. | 8 | $140 |
| PFIZER INC. | 5 | $77 |
| Amgen Inc. | 3 | $54 |
| Lundbeck LLC | 1 | $39 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Exact Sciences Corporation | 2 | $29 |
Products named: FARXIGA, VRAYLAR, Wegovy, Rybelsus, NURTEC ODT, Ozempic, REXULTI, OTEZLA.
Industry payments across IL — which companies pay providers there.
